EMBEDDED BD FOR FRONTIER SCIENCE COMPANIES
Your technology
is ready.
Your pipeline isn't.
I work directly with companies building frontier science technology — blockchain for science, AI and robotics for lab automation, and clinical-grade longevity biotech — to find and close their first B2B customers. Academic labs, biotech, longevity clinics.
THE GAP
Great science doesn't sell itself.
Blockchain is rebuilding how science is funded and how data is collected. AI and robotics are accelerating what happens in the lab. Longevity biotech is finding its first clinical customers. Different technologies with the same commercial gap. Founders are too deep in the product to build the pipeline. They know their technology but don’t have time to identify and close their first partners and customers — academic labs, biotech, and longevity clinics.
01
Founders know the science but have no time to build pipeline on top of it.
02
03
04
THE OFFER
Diagnose. Execute. Iterate.
I embed directly with your company. One goal: find the right customers and close them. Academic labs, early-stage biotech, longevity clinics. I start with a target map — who actually buys technology like yours, and why. Then I execute and iterate.
Outreach & Warm Intros
20–30 targeted contacts per month. Every intro is warm, domain-specific, and pre-qualified.
Partnership Negotiations
In the room. From first conversation to signed agreement.
Investor & Stakeholder Meetings
Prepare, attend, follow up. Institutional conversations that convert into concrete next steps.
Pipeline Reporting
Monthly: deals in progress, stage, pipeline value, next actions. Full visibility, no surprises.
Monthly retainer
Success fee on closed deals • Less than a junior BD hire
MONTHLY RETAINER STARTING FROM
Engagement terms depend on fund size and portfolio scope.
Ongoing retainer • Success fee on closed deals
HOW WE START
The 90-Day Sprint.
Every engagement starts with diagnosis. By month one you know exactly who to target and why. By month three you have live partnerships in negotiation and a pipeline with quantified value.
MONTH 1
Diagnose & target
Your ICP defined. Warm network mapped. First qualified conversations opened with academic labs, biotech teams, or longevity clinics that actually fit.
MONTH 2
ACTIVATE
50+ targeted contacts engaged. 10+ qualified conversations live. Every intro warm and domain-grounded.
MONTH 3
CONVERT
TRACK RECORD
Results that speak.
VITA DAO
Researcher Intake &
Funding Readiness
- 300+ researchers onboarded
- ~10 projects to funding-ready status
- Faster, cleaner governance decisions
CEREBRUMDAO
Partnerships & Funding
Strategy
- 50+ targeted stakeholders engaged
- 2 partnerships in active development
ARC
Longevity Hub Strategy
& Execution
Built the BD infrastructure for a longevity hub from scratch. Matched founders to investors by thesis fit. Ran capital conversations across a regulated biotech environment in Lisbon.
- $500M+ AUM engaged
- Curated founder–investor discussions
- Follow-on co-investment conversations
What stood out was his ability to structure interactions between investors and founders so conversations became more productive and follow-ups led to concrete next steps.
Michele focused on scaling and structuring our dealflow funnel. This made it much easier to move from inbound interest to clear funding decisions.
Why me
My network built over 8 years spans academic labs, DeSci protocols, longevity clinics, frontier science companies nd funds, and big pharma across the US, EMEA, and APAC. I’ve activated $3M+ in institutional partnerships across 10+ organizations selling emerging technologies to scientific and clinical buyers. That’s the environment your company is selling into.
Ready to build
your pipeline?
If you’re building frontier science technology — blockchain for science, AI and robotics for lab automation, or clinical-grade longevity biotech — and need to find your first real B2B customers or close your first strategic partnerships, let’s book a 30-minute diagnostic call.
Landing page developed by My Web Lab – Web Agency Milano